Defence Therapeutics Inc. (DTC.CN)

CAD 1.0

(21.95%)

Total Debt Summary of Defence Therapeutics Inc.

  • Defence Therapeutics Inc.'s latest annual total debt in 2023 was 1.74 Million CAD , up 0.02% from previous year.
  • Defence Therapeutics Inc.'s latest quarterly total debt in 2023 Q4 was 1.74 Million CAD , up 9.05% from previous quarter.
  • Defence Therapeutics Inc. reported annual total debt of 1.74 Million CAD in 2022, down 0.0% from previous year.
  • Defence Therapeutics Inc. reported annual total debt of - CAD in 2021, down 0.0% from previous year.
  • Defence Therapeutics Inc. reported quarterly total debt of 1.74 Million CAD for 2023 Q4, up 9.05% from previous quarter.
  • Defence Therapeutics Inc. reported quarterly total debt of 1.63 Million CAD for 2023 Q1, down -6.19% from previous quarter.

Annual Total Debt Chart of Defence Therapeutics Inc. (2023 - 2018)

Historical Annual Total Debt of Defence Therapeutics Inc. (2023 - 2018)

Year Total Debt Total Debt Growth
2023 1.74 Million CAD 0.02%
2022 1.74 Million CAD 0.0%
2021 - CAD 0.0%
2020 - CAD 0.0%
2019 - CAD 0.0%
2018 - CAD 0.0%

Peer Total Debt Comparison of Defence Therapeutics Inc.

Name Total Debt Total Debt Difference
Algernon Pharmaceuticals Inc. - CAD -Infinity%
Asep Medical Holdings Inc 20 Thousand CAD -8632.24%
BetterLife Pharma Inc. 245.23 Thousand CAD -612.156%
BioVaxys Technology Corp. - CAD -Infinity%
ChitogenX Inc. 3.87 Million CAD 54.93%
Rapid Dose Therapeutics Corp. 2.45 Million CAD 28.823%
Entheon Biomedical Corp. - CAD -Infinity%
Gemina Laboratories Ltd. 285.32 Thousand CAD -512.089%
Glow Lifetech Corp. 116.18 Thousand CAD -1403.174%
Lexston Life Sciences Corp. - CAD -Infinity%
Pharmala Biotech Holdings Inc. 253.53 Thousand CAD -588.834%
Doseology Sciences Inc. - CAD -Infinity%
MYND Life Sciences Inc. 3 Million CAD 41.785%
Nova Mentis Life Science Corp. - CAD -Infinity%
PharmaTher Holdings Ltd. - CAD -Infinity%
PreveCeutical Medical Inc. 3.83 Million CAD 54.45%
Telescope Innovations Corp. - CAD -Infinity%